No Increase in Malignancy Risk with Cladribine Tablets in Patients with Relapsing Multiple Sclerosis
Autor: | Galazka, A., Nolting, A., Cook, S., Leist, T., Comi, G., Montalban, X., Hicking, C., Dangond, F. |
---|---|
Zdroj: | In Multiple Sclerosis and Related Disorders November 2018 26:261-261 |
Databáze: | ScienceDirect |
Externí odkaz: |